Interleukin-1 Receptor-Like 1 Protein
"Interleukin-1 Receptor-Like 1 Protein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A receptor for INTERLEUKIN-33 that is related structurally to the interleukin-1 receptor. It contains three extracellular IMMUNOGLOBULIN-LIKE DOMAIN regions and associates with INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN upon binding IL-33 to initiate signaling. It may function in the response of HELPER T CELLS to INFLAMMATION.
| Descriptor ID |
D000072179
|
| MeSH Number(s) |
D12.776.543.750.705.852.420.300.375
|
| Concept/Terms |
Interleukin-1 Receptor-Like 1 Protein- Interleukin-1 Receptor-Like 1 Protein
- Interleukin 1 Receptor Like 1 Protein
- Interleukin 1 Receptor-Related Protein
- Interleukin 1 Receptor Related Protein
- Interleukin-33 Receptor
- Interleukin 33 Receptor
- Receptor, Interleukin-33
- IL1RL1 Protein
|
Below are MeSH descriptors whose meaning is more general than "Interleukin-1 Receptor-Like 1 Protein".
Below are MeSH descriptors whose meaning is more specific than "Interleukin-1 Receptor-Like 1 Protein".
This graph shows the total number of publications written about "Interleukin-1 Receptor-Like 1 Protein" by people in this website by year, and whether "Interleukin-1 Receptor-Like 1 Protein" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2017 | 8 | 5 | 13 |
| 2018 | 8 | 5 | 13 |
| 2019 | 1 | 2 | 3 |
| 2020 | 1 | 1 | 2 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Interleukin-1 Receptor-Like 1 Protein" by people in Profiles.
-
A possible role for ST2 as prognostic biomarker for COVID-19. Vascul Pharmacol. 2021 06; 138:106857.
-
An immune-based biomarker signature is associated with mortality in COVID-19 patients. JCI Insight. 2021 01 11; 6(1).
-
Serum-soluble ST2 as a novel biomarker reflecting inflammatory status and illness severity in patients with COVID-19. Biomark Med. 2020 12; 14(17):1619-1629.
-
The Predictive Role for ST2 in Patients with Acute Coronary Syndromes and Heart Failure. Curr Med Chem. 2020; 27(27):4479-4493.
-
Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial. Eur Heart J. 2019 10 21; 40(40):3345-3352.
-
Mast Cells in Cardiac Fibrosis: New Insights Suggest Opportunities for Intervention. Front Immunol. 2019; 10:580.
-
Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome. J Cardiovasc Med (Hagerstown). 2019 Feb; 20(2):81-90.
-
Disruption of IL-33 Signaling Limits Early CD8+ T Cell Effector Function Leading to Exhaustion in Murine Hemophagocytic Lymphohistiocytosis. Front Immunol. 2018; 9:2642.
-
IL-33/ST2 Axis in Organ Fibrosis. Front Immunol. 2018; 9:2432.
-
TGFß1-Smad Signaling Pathway Participates in Interleukin-33 Induced Epithelial-to-Mesenchymal Transition of A549 Cells. Cell Physiol Biochem. 2018; 50(2):757-767.